amphetamine has been researched along with lsp4-2022 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Acher, F; Gruca, P; Lasoń-Tyburkiewicz, M; Marciniak, M; Papp, M; Pilc, A; Wierońska, JM; Woźniak, M | 1 |
Acher, F; Cieślik, P; Conn, PJ; Kusek, M; Pilc, A; Rook, JM; Tantawy, MN; Tokarski, K; Wierońska, JM; Woźniak, M | 1 |
2 other study(ies) available for amphetamine and lsp4-2022
Article | Year |
---|---|
Involvement of GABAB Receptor Signaling in Antipsychotic-like Action of the Novel Orthosteric Agonist of the mGlu4 Receptor, LSP4-2022.
Topics: Amphetamine; Animals; Antipsychotic Agents; Cyclopentanes; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Excitatory Amino Acid Agonists; GABA Agents; Male; Mice, Knockout; Motor Activity; Phosphinic Acids; Pyrimidines; Receptors, GABA-B; Receptors, Metabotropic Glutamate; Recognition, Psychology; Schizophrenia; Social Behavior | 2016 |
Mutual activation of glutamatergic mGlu
Topics: Amphetamine; Animals; Antipsychotic Agents; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Male; Mice; Motor Activity; Phosphinic Acids; Receptor, Muscarinic M4; Receptors, Metabotropic Glutamate; Rodentia; Schizophrenia | 2018 |